MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

DownloadDownload image
Maturities of investments$22,000K Net cash provided byinvesting activities$15,316K Canceled cashflow$6,684K Net decrease incash, cash...-$5,746K Canceled cashflow$15,316K Prepaid expenses andother current assets-$2,633K Accounts payable(including related party...$1,812K Stock-based compensation$1,593K Depreciation andamortization$666K Other receivables(including related party...-$67K Proceeds from purchase ofespp shares-$131K Purchases of investments$6,442K Purchases of property andequipment$242K Net cash used inoperating activities-$20,950K Canceled cashflow$6,771K Net cash (used in)provided by financing...-$112K Canceled cashflow$131K Net loss-$23,516K Accrued expenses(including related party...-$4,003K Accretion of discounts andamortization of premiums on...$199K Operating leaseright-of-use asset and lease...-$3K Payments to taxingauthorities related to...$210K Payments on financeleases$33K
Cash Flow

Artiva Biotherapeutics, Inc. (ARTV)

Artiva Biotherapeutics, Inc. (ARTV)

source: myfinsight.com